FDA
-
-
-
-
-
-
-
Quanterix Releases Operating Results for First Quarter 2023
-
-
-
-
-
-
-
Mercy BioAnalytics Appoints Dawn Mattoon, PhD, as Chief Operating Officer
-
-
-
-
-
-
-
Quanterix Provides Operational and Preliminary Financial Highlights
-
-
-
-
-
-
-
Quanterix (QTRX) Stock Surges 20% as FDA Grants Breakthrough Device Designation to pTau-181 Blood Test
-
-
-
-
-
-
-
Quanterix Corporation Releases Operating Results for First Quarter 2021
-
-
-
-
-
-
-
After-Hours Stock Movers 01/11: (VOXX) (PXLW) (QTRX) Higher; (RDHL) (LMND) (NIO) Lower (more...)
-
-
-
-
-
-
-
Quanterix Receives National Institutes of Health RADx Contract to Advance Antigen Test for SARS-CoV-2 (COVID-19)
-
251,890 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All